Skip to main content

Table 4 Platinum-retreated status in the surgery group

From: Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ovarian cancer

Platinum-based regimen

Surgery group (N = 10)

Gemcitabine+oxaliplatin

1

Gemcitabine+nedaplatin

1

Paclitaxel+carboplatin

4

Paclitaxel+cisplatin

2

Paclitaxel+lobaplatin

2

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us